02:49 ETGenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hubprnewswire·Mar 12 at 01:52 AM300119+1.73%
Huachuang Securities: In the first three quarters, most vaccine varieties saw year-on-year growth in batch approvals, and pet vaccines continued to maintain a high growth rateZhitong·Oct 28, 2025 at 01:15 AM603392-0.13%600201+7.85%
RINGPU: A pilot production line for mycelium protein has been established, providing a foundation for industrialization and promotion conditionsZhitong·Oct 26, 2025 at 07:48 PM300119+1.73%
RINGPU: "Double Eleven" pet-related work has been fully promotedZhitong·Oct 26, 2025 at 06:59 PM300119+1.73%
RINGPU released its performance for the first three quarters, with a net profit attributable to the parent company of 362 million yuan, an increase of 45.64%Zhitong·Oct 24, 2025 at 04:11 AM300119+1.73%
RINGPU: The net profit for the third quarter was 106 million yuan, a year-on-year increase of 23.02%Zhitong·Oct 24, 2025 at 03:19 AM300119+1.73%
RINGPU plans to invest CNY 154 million to establish Tianjin Baorui, focusing on the pet industry chain-related targetsZhitong·Oct 14, 2025 at 06:34 AM300119+1.73%
Huachuang Securities: In August, the growth of vaccines for diarrhea, brucellosis, and feline trivalent was strong, and the raw materials for veterinary drugs are entering a peak season with price increasesZhitong·Sep 30, 2025 at 03:03 AM300119+1.73%600201+7.85%
RINGPU obtained a new veterinary drug registration certificateZhitong·Sep 30, 2025 at 03:01 AM300119+1.73%
RINGPU: Net profit in the first half of the year increased by 57.59% year-on-yearZhitong·Aug 25, 2025 at 06:33 AM300119+1.73%
Guohai Securities: The "Matthew Effect" in the animal protection industry intensifies, and pet pharmaceuticals and overseas expansion are expected to open up medium to long-term growth spaceZhitong·Aug 14, 2025 at 01:38 AM300119+1.73%688098+4.47%
RINGPU has obtained the clinical trial approval for veterinary biological productsZhitong·Jul 25, 2025 at 02:53 AM300119+1.73%
The animal vaccine sector continues to rise, with JINYU hitting the daily limitZhitong·Jul 16, 2025 at 12:37 AM300119+1.73%688136+3.63%
RINGPU: Expected net profit in the first half of the year to grow by 50%-70% year-on-yearZhitong·Jul 14, 2025 at 03:28 AM300119+1.73%
RINGPU plans to transfer 48.4213% equity of its controlling subsidiary Zhong'an Biotechnology for 115 million yuanZhitong·Jun 13, 2025 at 08:02 AM300119+1.73%
